[Comparative characteristics of M-cholinolytics in combined treatment of mixed urinary incontinence in women].
Laparoscopic retropubic urethropexy by Birch was followed by chemotherapy with m-cholinolytics in 30 women with mixed urinary incontinence. 15 patients received trospium chloride in a daily dose 30-45 mg and the other 15--oxibutinin hydrochloride in a daily dose 10-15 mg. A comparative analysis of the treatment results after 36 months of follow-up demonstrated higher safety of trospium chloride which showed the same efficacy with oxibutinin hydrochloride.
Artamonov
V A
VA
Rybnikov
S V
SV
D001561:Benzilates; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D010535:Laparoscopy; D008333:Mandelic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D009662:Nortropanes / Q000008:administration & dosage / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D013520:Urologic Surgical Procedures
D001561:Benzilates; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D009662:Nortropanes; C003330:trospium chloride; C005419:oxybutynin